Credit Suisse Ag Dyadic International Inc Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$4.93 - $10.26 $447,634 - $931,587
-90,798 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$2.58 - $6.6 $71,525 - $182,971
27,723 Added 43.95%
90,798 $472,000
Q4 2019

Feb 12, 2020
BUY
$5.02 - $6.66 $316,636 - $420,079
63,075 New
63,075 $327,000

Others Institutions Holding DYAI

# of Institutions
36
Shares Held
4.77M
Call Options Held
20.6K
Put Options Held
0
View Full List

About DYADIC INTERNATIONAL INC

DYAI Quotes by TradingView
  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email